147 results on '"Kristensen, Gunnar B"'
Search Results
2. DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses
3. CA-125 Early Dynamics to Predict Overall Survival in Women with Newly Diagnosed Advanced Ovarian Cancer Based on Meta-Analysis Data
4. CA-125 Early Dynamics to Predict Overall Survival in Women with Newly Diagnosed Advanced Ovarian Cancer Based on Meta-Analysis Data
5. miR‐200a/b/‐429 downregulation is a candidate biomarker of tumor radioresistance and independent of hypoxia in locally advanced cervical cancer
6. Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification
7. Salvage Radiation for Pelvic Relapse after Surgically Treated Endometrial Cancer
8. Additional file 1 of DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses
9. Prognostic significance of dysadherin expression in cervical squamous cell carcinoma
10. Prognostic Value of the Diversity of Nuclear Chromatin Compartments in Gynaecological Carcinomas
11. Genomic imbalances in endometrial adenocarcinomas – Comparison of DNA ploidy, karyotyping and comparative genomic hybridization
12. MRI Distinguishes Tumor Hypoxia Levels of Different Prognostic and Biological Significance in Cervical Cancer
13. Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity
14. Integrated Molecular Analysis of Undifferentiated Uterine Sarcomas Reveals Clinically Relevant Molecular Subtypes
15. Re: New Guidelines to Evaluate the Response to Treatment in Solid Tumors [Ovarian Cancer]
16. A study of weekly Taxol® in patients with recurrent platinum resistant ovarian cancer.
17. Integrated Molecular Analysis of Undifferentiated Uterine Sarcomas Reveals Clinically Relevant Molecular Subtypes
18. Metabolic mapping by use of high-resolution magic angle spinning 1H MR spectroscopy for assessment of apoptosis in cervical carcinomas
19. Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer
20. Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients
21. Egenskaper ved kreftcellenes DNA påvirker prognosen
22. Integrative Analysis of DCE-MRI and Gene Expression Profiles in Construction of a Gene Classifier for Assessment of Hypoxia-Related Risk of Chemoradiotherapy Failure in Cervical Cancer
23. Systematic analysis of circulating soluble angiogenesis-associated proteins in ICON7 identifies Tie2 as a biomarker of vascular progression on bevacizumab
24. Identification and Validation of Reference Genes for RT-qPCR Studies of Hypoxia in Squamous Cervical Cancer Patients
25. Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer
26. Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO)
27. Gene Expression Programs in Response to Hypoxia: Cell Type Specificity and Prognostic Significance in Human Cancers
28. Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO)
29. Quality of pathology reports for advanced ovarian cancer:are we missing essential information? An audit of 479 pathology reports from the EORTC-GCG 55971/NCIC-CTG OV13 neoadjuvant trial
30. Abstract 401: Gene expression signatures differentiate primary and metastatic uterine leiomyosarcoma.
31. Abstract 807: Eight candidate target genes of the recurrent 3p12-p14 loss in cervical cancer.
32. Abstract 4037: HIF1α signaling contributes to an aggressive hypoxic phenotype in cervical cancer.
33. Hypoxia-Induced Gene Expression in Chemoradioresistant Cervical Cancer Revealed by Dynamic Contrast-Enhanced MRI
34. The Prognostic Value of Adaptive Nuclear Texture Features from Patient Gray Level Entropy Matrices in Early Stage Ovarian Cancer
35. Genomic imbalances in endometrial adenocarcinomas - Comparison of DNA ploidy, karyotyping and comparative genomic hybridization
36. Membranous Expression of Ectodomain Isoforms of the Epidermal Growth Factor Receptor Predicts Outcome after Chemoradiotherapy of Lymph Node–Negative Cervical Cancer
37. Gene Dosage, Expression, and Ontology Analysis Identifies Driver Genes in the Carcinogenesis and Chemoradioresistance of Cervical Cancer
38. Human Papillomavirus DNA and E6/E7 mRNA Status in Relation to Survival of Patients Treated for Cervical Squamous Cell Carcinoma
39. Expressions of EphA2 and EphrinA-1 in early squamous cell cervical carcinomas and their relation to prognosis
40. Metabolic mapping by use of high-resolution magic angle spinning 1H MR spectroscopy for assessment of apoptosis in cervical carcinomas
41. Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer
42. Presence of E6 and E7 mRNA from Human Papillomavirus Types 16, 18, 31, 33, and 45 in the Majority of Cervical Carcinomas
43. Proteomic Analysis of Malignant Ovarian Cancer Effusions as a Tool for Biologic and Prognostic Profiling
44. High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection
45. Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients
46. Apolipoprotein E Is Required for Cell Proliferation and Survival in Ovarian Cancer
47. Gene Expression Patterns in Ovarian Carcinomas
48. Fibroblast Growth Factor Receptor 3 (FGFR3)–Analyses of the S249C Mutation and Protein Expression in Primary Cervical Carcinomas
49. High Levels of Genomic Aberrations in Serous Ovarian Cancers Are Associated with Better Survival.
50. Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.